Abstract
The 2004 ISHLT working formulation was developed to resolve inconsistencies between centers and is characterized by grouping former low-grade acute cellular rejection (ACR) to current grade 1R. The 1R classification as guidance on prognosis and treatment has not yet been well studied. We aimed to investigate the implications of early recurrent 1R rejections on the long term outcomes after heart-transplantation (HTx).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
